Literature DB >> 32557549

Is it time to rethink checkpoint blockade therapy in non-Hodgkin lymphoma?

Elizabeth H Phillips1,2, Tim M Illidge1,2.   

Abstract

Entities:  

Keywords:  checkpoint blockade therapy; malignancies; non-Hodgkin lymphoma

Year:  2020        PMID： 32557549     DOI： 10.1111/bjh.16854

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  1 in total

1.  Checkpoint Blockade Treatment May Sensitize Hodgkin Lymphoma to Subsequent Therapy.

Authors:  Nicole A Carreau; Orrin Pail; Philippe Armand; Reid Merryman; Ranjana H Advani; Michael A Spinner; Alex Herrera; Robert Chen; Sarah Tomassetti; Radhakrishnan Ramchandren; Muhammad S Hamid; Sarit Assouline; Raoul Santiago; Nina Wagner-Johnston; Suman Paul; Jakub Svoboda; Steven Bair; Stefan Barta; Yang Liu; Sunita Nathan; Reem Karmali; Madelyn Burkart; Pallawi Torka; Kevin David; Catherine Wei; Frederick Lansigan; Lukas Emery; Daniel Persky; Sonali Smith; James Godfrey; Julio Chavez; Yuhe Xia; Andrea B Troxel; Catherine Diefenbach
Journal:  Oncologist       Date:  2020-08-28       Impact factor: 5.837
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.